Probiotic bacteria and biosurfactants for nosocomial infection control: a hypothesis
- PMID: 19201053
- DOI: 10.1016/j.jhin.2008.12.008
Probiotic bacteria and biosurfactants for nosocomial infection control: a hypothesis
Abstract
The adaptation of strict hygienic practices by healthcare personnel as well as the implementation of appropriate cleaning and disinfection measures form the basis of infection control policies. However, nosocomial infections constitute a considerable problem even in hospitals with meticulous infection control programmes. This should prompt biomedical researchers to evaluate the efficacy and safety of novel infection control measures. There is preliminary evidence that probiotic type micro-organisms may antagonise the growth of nosocomial pathogens on inanimate surfaces. We therefore propose the hypothesis that environmental probiotic organisms may represent a safe and effective intervention for infection control purposes. We suggest that probiotics or their products (biosurfactants), could be applied to patient care equipment, such as tubes or catheters, with the aim of decreasing colonisation of sites by nosocomial pathogens. This could potentially impede a central step in the pathogenesis of nosocomial infections.
Similar articles
-
Review of mobile communication devices as potential reservoirs of nosocomial pathogens.J Hosp Infect. 2009 Apr;71(4):295-300. doi: 10.1016/j.jhin.2008.12.009. Epub 2009 Jan 24. J Hosp Infect. 2009. PMID: 19168261 Review.
-
Inconsistencies in endoscope-reprocessing and infection-control guidelines: the importance of endoscope drying.Am J Gastroenterol. 2006 Sep;101(9):2147-54. doi: 10.1111/j.1572-0241.2006.00712.x. Am J Gastroenterol. 2006. PMID: 16968511 Review.
-
Re-evaluation of current A0 value recommendations for thermal disinfection of reusable human waste containers based on new experimental data.J Hosp Infect. 2010 May;75(1):62-5. doi: 10.1016/j.jhin.2010.01.020. Epub 2010 Mar 24. J Hosp Infect. 2010. PMID: 20338666
-
Probiotics for the prevention of nosocomial pneumonia: current evidence and opinions.Curr Opin Pulm Med. 2008 May;14(3):168-75. doi: 10.1097/MCP.0b013e3282f76443. Curr Opin Pulm Med. 2008. PMID: 18427239 Review.
-
Strategies for the prevention of hospital-acquired infections in the neonatal intensive care unit.J Hosp Infect. 2008 Apr;68(4):293-300. doi: 10.1016/j.jhin.2008.01.011. Epub 2008 Mar 7. J Hosp Infect. 2008. PMID: 18329134 Review.
Cited by
-
Evaluation of the Probiotic Properties of Lacticaseibacillus casei 431® Isolated from Food for Special Medical Purposes§.Food Technol Biotechnol. 2023 Dec;61(4):418-429. doi: 10.17113/ftb.61.04.23.8045. Food Technol Biotechnol. 2023. PMID: 38205053 Free PMC article.
-
Production and structural characterization of Lactobacillus helveticus derived biosurfactant.ScientificWorldJournal. 2014;2014:493548. doi: 10.1155/2014/493548. Epub 2014 Nov 19. ScientificWorldJournal. 2014. PMID: 25506070 Free PMC article.
-
Biofilm formation of Candida Spp. isolated from the vagina and antibiofilm activities of lactic acid bacteria on the these Candida Isolates.Afr Health Sci. 2020 Jun;20(2):641-648. doi: 10.4314/ahs.v20i2.12. Afr Health Sci. 2020. PMID: 33163025 Free PMC article.
-
Spatiotemporal bio-shielding of bacteria through consolidated geometrical structuring.NPJ Biofilms Microbiomes. 2022 May 9;8(1):37. doi: 10.1038/s41522-022-00302-2. NPJ Biofilms Microbiomes. 2022. PMID: 35534500 Free PMC article.
-
Exploring the Hospital Microbiome by High-Resolution 16S rRNA Profiling.Int J Mol Sci. 2019 Jun 25;20(12):3099. doi: 10.3390/ijms20123099. Int J Mol Sci. 2019. PMID: 31242612 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical